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Abstract
In patients at risk because of heart disease, bacteremias induced by invasive dental treatments have been reported 
as a cause of bacterial endocarditis (BE) - a serious disorder that continues to involve a high mortality. As a result, 
different scientific societies have supported recommendations for the administration of antibiotics prior to invasive 
dental treatments, in order to neutralize bacteremia. In this context, the recommendations of the American Heart 
Association (AHA) are the most widely used in our setting. Advances in our knowledge of the etiopathogenesis of 
bacterial endocarditis have placed increasingly less importance on invasive dental treatments as a causal factor (the 
AHA again reduced the number of cases in which antibiotic prophylaxis is recommended, on occasion of its latest 
guidelines update in 2007) - with increasingly greater importance being placed on factors associated with hygiene 
and oral health.
The present study offers a critical review of the relationship between dental treatment, bacteremia and bacterial 
endocarditis.
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Introduction
The presence of germs in the bloodstream is referred to as 
bacteremia. Blood cultures are used to identify bacteria 
in blood. The identification of certain virulent germs in 
blood (Neisseria meningitidis, Streptococcus pneumoniae, 
Salmonella typhi) is of diagnostic value in application to 
certain diseases. The difficulty arises when the microorga-
nism detected in blood is a usual colonizer of the skin or 
mucosal membranes, and moreover does not prove positive 
on a continuous basis in blood cultures. Thus, in a patient 
with clinical manifestations of disease (e.g., bacterial en-
docarditis (BE)), successive blood cultures must be made, 
with an evaluation of other signs and symptoms in order 
to establish a precise diagnosis. Although dental profes-
sionals must be familiarized with the manifestations of 
such diseases, it is more relevant for them to know whether 
their dental activity is able to induce bacteremias, and to 
establish the degree in which such bacteremia can cause 
pathology in their patients. The present study provides a 
review of these aspects.
The germs in the oral cavity
The oral cavity is intensely colonized by bacteria. The 
maximum concentration is found in bacterial plaque, 
where it is estimated that there are between 1011 and 1012 
microorganisms per gram of wet weight - though there 
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are also abundant bacteria on the back of the tongue and 
in the cheek and palatal mucosa (1). Up to 200 different 
bacterial species have been isolated from a single oral 
cavity in the course of time, though the usual residents 
number about 20. Although there are differences among 
the different oral ecosystems, globally the most abundant 
microorganisms are Streptococci of the viridans group 
(mitis, sanguis, salivarius, etc.) (2).
Any breach in the oral mucosal barrier places the internal 
body environment in contact with a highly contaminated 
ecosystem - resulting in the penetration of microorganisms 
into the bloodstream. It is then possible to identify the 
germs in the blood through blood cultures. Although it 
has been suggested that such bacteremia may be the cause 
of a number of processes (distant abscesses, kidney da-
mage, failed joint prostheses, etc.), the disease with which 
bacteremia traditionally has been associated is bacterial 
endocarditis (BE) - an infection of the endocardium that 
produces general or systemic symptoms of infection, em-
bolic phenomena and endocardial vegetations (Figures 1 
and 2). Although patient fatalities associated with such 
alterations have decreased significantly, the mortality rate 
remains in the range of 5-11%. The germs most often rela-
ted with BE are Streptococcus viridans and Staphylococ-
cus aureus (21% and 23%, respectively, in absolute terms)
(3) -though other microorganisms capable of causing BE 
have also been isolated from the oral cavity (enterococci, 
diphteroides, Coxiella, fungi, etc.). It comes as no surprise 
that some medical textbooks affirm that “in the classical 
form of endocarditis affecting native valve tissue, the most 
common antecedent is dental manipulation without the 
pertinent antibiotic prophylaxis, thus resulting in bacte-
remia due to Staphylococcus viridans…” (4).
It is essential for dental professionals to know whether 
bacteremia associated with the provided dental treatment 
is really capable of causing BE, if  the risk is general for all 
patients and, if  so, what measures can be taken to avoid 
such complications.
Dental treatment and bacteremia
Dental extraction is undoubtedly the oral surgical procedure 
where most research into bacteremia has been made ever 
since the relationship between both phenomena was esta-
blished in the mid-twentieth century - though dental extrac-
tion is not the only example (5,6) (Table 1). The frequency of 
bacteremia is estimated to be between 39-100%, and Strep-
tococcus viridans is the bacterium most often identified in 
the majority of studies (7,8), both in determinations made 
in the immediate postoperative period and after a certain 
period of time (minutes). A characteristic of such bacte-
remia is its transient nature, since the microorganisms are 
cleared from the bloodstream within a few minutes - though 
recently Tomas et al. have reported bacteremia in 20% of 
patients one hour after completing the surgical procedure 
(tooth extraction under general anesthesia) (8).
Studies have been made to determine whether oral hygiene 
and health are related to the degree of bacteremia detec-
ted after oral surgical operations. The results have been 
contradictory, for although some authors have recorded 
an increased prevalence of bacteremia with poorer oral 
health, other investigators have reported no differences 
(9). Some authors have even obtained opposite results, 
with higher bacteremia percentages at some point during 
the study (sampling after 15 minutes and at one hour) in 
subjects without spontaneous gingival bleeding (8).
Oral dynamics versus dental treatment as a cause of 
bacteremia
Transient bacteremia is produced not only as a result of 
dental manipulation. Daily life activities such as eating, 
chewing gum, brushing the teeth or using toothpicks also 
induce bacteremia detectable by means of blood cultures 
in a variable percentage of subjects (10).
In a study carried out by Carrol in 1980, it was seen that 
patients who used dental floss on a daily basis showed no 
Fig. 2. Ultrasound view of  vegetation in mitral valve. 
V.I: left ventricle. A.I.: left atrium. V.M.C.: closed mitral 
valve.
Fig. 1. Ultrasound view of vegetation in aortic valve. 
V.I: left ventricle. A.I.: left atrium. V.M.A.: open mitral 
valve.
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bacteremia following its use. However, when these same 
patients stopped flossing for 1-4 days, bacteremia was 
detected in 86% of cases after reintroducing the habit.
The fact that daily life activities such as these can induce 
significant bacteremia seriously questions the idea that den-
tal manipulation is the most relevant cause of endocarditis 
- unless the intensity of bacteremia is significantly greater 
in dental extractions, and thus results in an increased risk 
of developing BE. However, the intensity of bacteremia 
produced by dental treatment (extraction) is similar to that 
induced by the aforementioned activities of daily living (less 
than 1000 colony forming units (CFU)/ml) (11).
According to a survey conducted in Spain in 1997, in-
volving 1351 individuals, 26.5% had visited the dentist in 
the previous 6 months, 12.1% in the previous 6 months 
to one year, 24.4% in the previous 1-2 years, and 35.4% 
had not seen the dentist in over two years (12). The reason 
for the last dental visit, among the 1029 subjects that had 
visited the dentist at some time, was a dental checkup or 
cleaning in 26.9% of the cases, tooth extraction in 24.4%, 
and endodontic treatment in 3.2% (only the activities con-
sidered to constitute a risk of bacteremia are reported). 
Based on these data, and assuming that extraction and 
tartar removal produce similar bacteremia rates (between 
39-100%)(5,6), it can be estimated that 5.6-14.4% of the 
population presented transient bacteremia as a result of 
dental intervention in the 6 months prior to the study; 
that 2.6-6.6% of the population developed bacteremia 
between 6 months and one year before the study; and 
that 5.2-13.3% of the population presented bacteremia 
1-2 years before consultation. Based on the data from the 
same study, and accepting that tooth brushing produces 
bacteremia in 20-68% of cases, it was seen that brushing 
during a 6-month period caused between 108 and 367 
bacteremia episodes in 31.3% of the population, 72-245 
episodes in 29.5%, and 36-122 episodes of bacteremia in 
22.7% of the study population. In regard to chewing, and 
assuming that the latter produces bacteremia in 7-51% of 
the cases and that 100% of the population eats at least 
two meals a day, it can be estimated that the number of 
bacteremia episodes as a consequence of chewing ranges 
from 25-275 over a period of 6 months.
On the other hand, it must be added that in studies of 
bacteremia, between 0-23% of the subjects show posi-
Dental treatment Prevalence Source
Endodontics
30%
11% (with PCR)
31-54% (only anaerobes)
(Savarrio L, 2005)
(Debelian Gj, 1998)
Nasotracheal intubation 12.3% (Oncag O, 2005)
Local anesthesia
16% oral infiltration; 97% 
intraligamentous
(Roberts Gj, 1998)
Prior to dental manipulation
2.5%
9.3% (general anesthesia)
23%
19% 
0% 
8% (general anesthesia)
(Erverdi N, 2001)
(Roberts GJ, 2000)
Lucas VS, 2002)
(Lucas VS, 2007) 
(Rosa E, 2005; Schlein RA, 1991)
(Roberts GJ, 1998)
Extraction
88% (50% one minute after 
incision, 44% immediately after 
extraction)
96.2% after 30 sec., 20% after one 
hour
89-94%
43-54%
(Rajasuo A, 2004)
(Tomas I, 2007)
(Lockhart PB, 1996)
(Roberts GJ, 1998)
Suture removal 5% (King RG, 1998)
Orthodontics
Removal brackets
Removal palatal Haas expander
Tooth brushing with orthodontic 
treatment
Fitting brackets
2.5%
26%
50%
25%
7.5%
32.1%
(Erverdi N, 2001)
(Lucas VS, 2007)
(Rosa E, 2005)
(Schlein RA, 1991)
(Erverdi N, 2001)
(Roberts GJ, 1997)
Periodontal probing
40% (patients with periodontitis)
10% (patients with gingivitis)  (Daly CG, 2001)
Tartar removal 24.5% (Roberts, 1997)
Table 1. Prevalence of bacteremia associated with dental treatments.
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tive bacteremia before any kind of  oral manipulation 
(13,14). As pointed out by Tomas et al. (8), most positive 
cultures detected from the blood sample prior to dental 
manipulation could correspond to bacteremia secondary 
to nasotracheal intubation (Table 1). However, there are 
also studies that detect baseline bacteremia in patients not 
subjected to general anesthesia, and who obviously have 
undergone no prior manipulation other than vein puncture 
(14,15). We have found no study in the literature centered 
on such presumed spontaneous bacteremia or on their 
causal relation to bacterial endocarditis (BE).
In this section it can be concluded that not only tooth 
extractions but also many other dental techniques and 
even daily life activities can produce bacteremia. Indeed, 
any activity producing a breach in the oral mucosal barrier 
and allowing contact between the oral environment and 
the bloodstream can lead to bacteremia.
Bacteremia induced by dental treatment and bacterial 
endocarditis
Having reached this point, it is very important for the 
dental professional to know the pathogenic potential of 
such bacteremia episodes of oral origin.
As has been commented above, the identification in blood 
and in the oral cavity of the same germs, and the fact that 
Streptococcus viridans is the cause of about 50% of all 
cases of native cardiac valve BE, gave support to the idea 
that dental manipulation - and specifically extraction - is 
one of the main causes of BE. Some texts even continue 
to consider such manipulation to be the main cause of the 
disease (4). however, this idea is not deeply questioned. 
Krcmery et al. (16) reviewed 339 cases of BE seen between 
the years 1991 and 2001. Of these cases, 29.2% were caused 
by staphylococci and 15% by streptococci. A history of 
dental surgery was noted in 13.2% of the patients, thus 
constituting the second most important risk factor after 
rheumatic fever (24.2%). The authors also noted that a 
history of dental surgery was much less frequent in the 
group of patients seen between 1997-2001 than in those 
seen between 1991-1997 (20% versus 5%). Hricak et al. 
(17) also identified a decrease in dental surgery as a risk 
factor in a series of 606 patients with BE seen in the period 
between 1984 and 2006.
Lascasin, in a case-control series involving 171 patients 
with BE, found no association between overall oral 
procedures and an increased risk of BE. Root rasping 
procedures and root canal treatments did show a certain 
increase in the risk of BE, though statistical significance 
was not reached (p=0.065).
In our setting, Castillo et al. recorded no antecedents of 
dental treatment in a group of 49 patients with BE in the 
absence of predisposing heart disease seen between 1987 
and 1997 (18). A relevant aspect documented by Wilson 
et al. is that many of the studies in which a relationship 
is established between oral procedures and BE consider a 
period of up to 6 months between both events. Considering 
that the incubation period of the disease is no more than 
15 days in 85% of all patients, it is very likely that many of 
the cases of BE attributed to dental treatment are actually 
unrelated to the latter (11).
In a recent study, Duval et al. estimated the risk of BE 
in patients with predisposing cardiac factors to be one in 
every 46,000 procedures carried out without antibiotic 
prophylaxis. More specifically, the authors estimate the 
risk of  BE to be one case in every 10,700 procedures 
without prophylaxis in patients with a valve prosthesis, 
and one case in every 54,300 procedures in patients with 
predisposing factors on native valve tissue. The investi-
gators estimated that 37 of the 1370 cases of BE (2.7%) 
diagnosed in France during one year were possibly related 
to invasive treatments without antibiotic protection, which 
reach percentages of up to 62% (19).
Somewhat lesser risk levels were reported by Pallasch, who 
on the assumption that dental treatments are responsible 
for 1% of all cases of BE, estimated the risk in the gene-
ral population to be one case of BE for every 14 million 
dental procedures. In patients at risk, the estimate was one 
case of BE for every 114,000 procedures in individuals 
with heart valve prostheses, and one case in every 95.00 
procedures in patients with previous BE (20). Thus, the 
available information suggests that the risk of causing BE 
as a consequence of dental procedures is low.
Antibiotic prophylaxis in dental treatments
Once the risk has been identified, the next step is to deter-
mine whether it can be avoided, and in what way.
According to Ito, the first reference to the association 
between oral bacteria and BE was published in 1908 
(Horder T. Infective endocarditis. Q J Med 11:319-23). 
In 1935, Okell and Elliot published in The Lancet that 
bacteremia appears after tooth extraction (61% of cases 
in their series), and that positive blood cultures are obser-
ved in 11% of patients with deficient oral hygiene. On the 
basis that most of the germs found in blood after tooth 
extraction correspond to Streptococcus viridans, and that 
the latter together with staphylococci are responsible for 
most cases of  BE, many scientific societies established 
recommendations for antibiotic prophylaxis with a view 
to neutralizing the deleterious effects of  transient bac-
teremia (e.g., the American Heart Association (AHA), 
the Japanese Circulation Society, the British Society for 
Antimicrobial Chemotherapy, the Agence Française de 
Securité Sanitaire des Produits de Santé, etc.). The most 
widely accepted of these recommendations in our setting 
are the guidelines of  the AHA, which since 1955 (the 
year in which its first recommendations were published) 
has edited 9 updates in the light of new knowledge in the 
field. The latest update of the AHA guidelines took place 
in 2007 (11). Table 2 details the cardiac disorders in which 
prophylaxis is advised, while Table 3 specifies the timing, 
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Heart valve prostheses.
Prior infectious endocarditis.
Congenital heart disease (CHD)*.
Untreated cyanotic CHD, including shunts and palliative ducts.
Congenital heart defect fully repaired with material or prosthesis, involving surgery or catheter, in the 6 
previous months §.
CHD, repaired but with residual defects in or adjacent to the material or prosthesis (thus inhibiting 
epithelization).
Heart transplant patients that develop valve disease.
*Prophylaxis is only recommended in the following three situations. Not recommended for any other form 
of CHD.
§ Prophylaxis is recommended because re-epithelization of the prosthetic material takes place in the 6 
months following placement.
Antibiotic regimens for dental procedures
Patient condition Drug
Single dose 30-60 minutes before dental 
treatment
Adults Children
Oral route Amoxicillin 2 g 50 mg/kg
Unable to take oral 
medication
Ampicillin
or
cefazolin or ceftriaxone
2 g IM* or IV†
1 g IM or IV
50 mg/kg IM or IV
50 mg/kg IM or IV
Allergic to penicillins or 
ampicillin via oral route
Cephalexin‡§
or
Clindamycin
or
azithromycin or clarithromycin
2 g
600 mg
500 mg
50 mg/kg
20 mg/kg
15 mg/kg
Allergic to penicillins 
or ampicillin via oral 
route, and unable to 
take oral medication
Cefazolin or ceftriaxone
or
clindamycin
1 g IM or IV
600 mg IM or IV
50 mg/kg IM or IV
20 mg/kg IM or IV
Table 2. Heart disorders associated with an increased risk of endocarditis, and for which prophylaxis is recommended prior 
to dental treatments.
*Prophylaxis is only recommended in the following three situations. Not recommended for any other form of CHD.
§ Prophylaxis is recommended because re-epithelization of the prosthetic material takes place in the 6 months following pla-
cement.
Reproduced with permission from: Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: Guidelines 
from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis and 
Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council 
on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. 
JADA 2007;138(6):739-60. © 2007 American Dental Association. Excerpted by JADA with permission of Circulation.
Table 3. Antibiotic treatment regimens for the prevention of bacterial endocarditis in dental procedures.
* IM: Intramuscular
† IV: Intravenous
‡ Or other first or second generation cephalosporin at equivalent doses for children and adults
§ The cephalosporins are not to be used in patients with a history of anaphylaxis, angioedema or urticaria with penicillins or 
ampicillin
Reproduced with permission from: Wilson W, Taubert KA, Gewitz M et al. Prevention of infective endocarditis: Guidelines 
from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis and 
Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council 
on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. 
JADA 2007;138(6):739-60. © 2007 American Dental Association. Excerpted by JADA with permission of Circulation.
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dose and type of antibiotic recommended, depending on 
the clinical situation of the patient. In addition to patients 
with heart disease, some authors recommend antibiotic 
prophylaxis in inflammatory joint diseases, immunosu-
ppression, type 1 diabetes, certain situations involving 
joint prostheses (less than two years since implantation, 
and a history of prior prosthetic infection), denutrition, 
hemophilia, transplants, uncontrolled diseases (liver and 
kidney failure), and splenectomized patients (21).
The current tendency is to recommend antibiotic pro-
phylaxis in increasingly fewer patients. The previous 
recommendations of the AHA (1997) contemplated pro-
phylaxis for moderate risk categories for BE (mitral valve 
prolapse, hypertrophic myocardiopathy, acquired valve 
dysfunction - rheumatic fever - and non-cyanotic congeni-
tal cardiac malformations). The current recommendations 
do not include these processes as tributary to prophylaxis. 
Modifications have also been introduced in the dental 
procedures requiring prophylaxis. Thus, prophylaxis is 
now advised in all procedures involving manipulation 
of the gingival tissue or periapical region, or perforation 
of the oral mucosa. Prophylaxis is not recommended in 
anesthetic infiltrations through uninfected tissues, the 
placement of  orthodontic brackets, the exfoliation of 
primary teeth, and bleeding secondary to trauma of the 
oral mucosa and lips, among others.
Another tendency that has become consolidated in the suc-
cessive recommendations is the reduction of the duration 
of prophylaxis. Thus, from the 5 days and up to 21 antibio-
tic doses of the first recommendations, we have dropped 
to a single dose administered between 30 and 60 minutes 
before the intervention - amoxicillin being the main drug 
advised in the different prophylactic protocols.
Controversy regarding the prevention of BE with an-
tibiotics in dental treatments
Many authors call for reflection upon the usefulness and 
safety of these prophylactic measures. Although they may 
prove very useful in a given individual, the cost / benefit 
analysis is not favorable to antibiotic prophylaxis when 
taking into account that even if  100% efficacy is assumed 
when administered correctly, the number of  cases of 
BE that could be avoided in the course of a year is very 
limited (22).
However, the effectiveness of prophylaxis by no means 
reaches 100%. Diz et al. studied percentage bacteremia 
in patients subjected to tooth extraction under general 
anesthesia with and without antibiotic prophylaxis, and 
recorded bacteremia initially and after 30 seconds, 15 mi-
nutes and one hour. The initial prevalence of bacteremia 
was 96% for the control group, 46% for amoxicillin, 85% 
for clindamycin and 57% for moxifloxacin - the values 
dropping to 20%, 4%, 22% and 7% after one hour (23).
Lockhart et al. obtained similar results on examining bac-
teremia in children subjected to dental treatments under 
general anesthesia. In effect, bacteremia was observed in 
84% of the patients not administered prophylaxis and in 
33% of those given amoxicillin (24).
Another point of controversy is the possibility that the 
massive use of antibiotics for prophylactic purposes may 
be contributing to the increase in bacterial resistances. 
Groppo et al. studied antibiotic resistance among the 
staphylococci and streptococci of  saliva and skin in 
patients at high risk of BE. They found 53.3% of the sta-
phylococci and 16.7% of the streptococci to be resistant 
to amoxicillin; 23.3% of the streptococci were resistant to 
azithromycin and clarithromycin; and 26.7% to clindamy-
cin (25). Smith et al. likewise documented relevant levels 
of antibiotic resistance in Streptococcus viridans isolated 
from blood cultures. In this sense, 27% of Streptococcus 
oralis proved resistant to penicillin, and 6% to clindamy-
cin. The corresponding resistance figures for Streptococcus 
mitis were 11% and 3%, respectively (26).
We have found no publications exploring the true risk 
of fatal adverse reactions with use of the antibiotics re-
commended by the AHA, and the latter points out that 
during the 50-year history of its guidelines, no fatal cases 
of anaphylaxis secondary to antibiotic prophylaxis have 
been documented. However, the possible adverse effects of 
antibiotics must be taken into account, since some studies 
have reported approximately 2.9% of  all adverse drug 
reactions to be a result of amoxicillin use - including skin 
reactions (82%), gastrointestinal alterations (7%), liver 
problems (1%) and hematological complications (1%)(27). 
Thus, the greater the indiscriminate use of antibiotics, the 
greater the probability that the risk of adverse reactions 
may exceed the risk of bacterial endocarditis.
Current trends in bacterial endocarditis prophylaxis 
among dental professionals
As has been commented, during 50 years dental professio-
nals have attempted to theoretically prevent BE through 
prophylactic antibiotic use when providing oral surgical 
treatments in patients at risk. This attitude has gradually 
changed over time, however. In recent years, the provision 
of optimum oral health in patients at risk of developing BE 
has centered attention as a decisive factor for preventing 
the disease. Slots points out that periodontal pathology 
causes transient bacteremia, and that certain diseases such 
as BE, aspiration pneumonia, disseminated candidiasis, 
septicemia, etc., can be associated to such oral microorga-
nisms (28). Ayadi et al. reported buccodental lesions to be 
the probable cause in 59.5% of all patients with BE, and 
considered the latter to be more closely related to deficient 
oral hygiene than to incorrect dental treatments (29). The 
many publications identifying an association between pe-
riodontal disease and other oral alterations on one hand, 
and ischemic heart disease (acute myocardial infarction) 
on the other (30), as well as the finding of oral bacteria 
in atheroma plaques - particularly in patients with active 
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periodontal disease (31), support a possible relationship 
between oral disease and cardiac disorders (including BE). 
However, in the same way as with antibiotic prophylaxis 
in dental treatments, we lack the necessary scientific 
evidence to firmly conclude that transient bacteremia 
caused by routine activities is responsible for most cases 
of BE, or that good oral health would avoid or reduce 
the risk of endocarditis. Most authors point to the need 
for randomized, multicenter clinical trials to examine this 
hypothesis more in depth.
To summarize, the American Heart Association (AHA) 
recognizes that the effectiveness of its recommendations is 
not clear, and defines them as corresponding to class IIb 
(i.e., a variety of opinions exist, or there is conflict in the 
evidence on the usefulness or efficacy of the recommen-
dations - their usefulness / efficacy ratio being deficiently 
established by the existing evidence / opinion), with B 
level evidence (the data are derived from a single rando-
mized trial or from non-randomized studies). In effect, 
there is no evidence of the efficacy of BE prophylaxis 
with penicillins; the clinical benefit of such prophylaxis 
has not been shown to outweigh the costs and risks; and 
there is a lack of scientific support of the quality of the 
recommendations regarding prophylaxis made by the di-
fferent scientific societies. Despite the above, however, we 
coincide with Carmona et al. (32) that it seems prudent, 
at least from the medical-legal perspective, to administer 
antibiotic prophylaxis to those patients with prior bacterial 
endocarditis or with heart valve prostheses. In sum, we feel 
it advisable to follow the indications of the AHA regarding 
the prophylaxis of BE, providing the patient with the ne-
cessary information on the associated risks and benefits, 
and obtaining informed consent in each case.
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